Telesis Bio Reports Second Quarter 2023 Financial Results :

-- Total revenue of $8.7M in 2QFY23 - increased by 53% year over yearSAN DIEGO, Aug. 10, 2023 -- Telesis Bio Inc. , a leader in automated multi-omic and synthetic biology solutions, today reported...
-Today at 04:07 pm- MarketScreener

Related Keywords

San Diego , California , United States , Jen Carroll , Toddr Nelson , Paul Meister , Nasdaq , Gibson Assembly , Novalis Lifesciences , Telesis Bio Inc , Pfizer , Library Prep , Gibson , Thermofisher Scientific , Golden Gate , Plasmid Sequencing , Conference Call , Telesis Bio , Private Securities Litigation Reform Act , Risk Factors , Quarterly Report , Operations Financial , Months Ended , Sheet Data , Markets ,